Influenza virus and SARS-CoV-2: pathogenesis and host responses in the respiratory tract

T Flerlage, DF Boyd, V Meliopoulos… - Nature Reviews …, 2021 - nature.com
Influenza viruses cause annual epidemics and occasional pandemics of respiratory tract
infections that produce a wide spectrum of clinical disease severity in humans. The novel …

The Japanese clinical practice guidelines for management of sepsis and septic shock 2020 (J-SSCG 2020)

M Egi, H Ogura, T Yatabe, K Atagi, S Inoue, T Iba… - Journal of intensive …, 2021 - Springer
Abstract The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic
Shock 2020 (J-SSCG 2020), a Japanese-specific set of clinical practice guidelines for sepsis …

Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021

L Evans, A Rhodes, W Alhazzani, M Antonelli… - Critical care …, 2021 - journals.lww.com
Sepsis is life-threatening organ dysfunction caused by a dysregulated host response to
infection (1). Sepsis and septic shock are major healthcare problems, impacting millions of …

Untuned antiviral immunity in COVID-19 revealed by temporal type I/III interferon patterns and flu comparison

IE Galani, N Rovina, V Lampropoulou… - Nature …, 2021 - nature.com
A central paradigm of immunity is that interferon (IFN)-mediated antiviral responses precede
pro-inflammatory ones, optimizing host protection and minimizing collateral damage,. Here …

ECCO guidelines on the prevention, diagnosis, and management of infections in inflammatory bowel disease

T Kucharzik, P Ellul, T Greuter, JF Rahier… - Journal of Crohn's …, 2021 - academic.oup.com
The introduction and broad use of new immunosuppressive agents, including biologic
agents and JAK inhibitors, have revolutionised treatment of inflammatory bowel disease …

Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19)

W Alhazzani, MH Møller, YM Arabi, M Loeb… - Intensive care …, 2020 - Springer
Background The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is
the cause of a rapidly spreading illness, Coronavirus Disease 2019 (COVID-19), affecting …

Oral nirmatrelvir–ritonavir as postexposure prophylaxis for Covid-19

J Hammond, C Yunis, RJ Fountaine… - … England Journal of …, 2024 - Mass Medical Soc
Background Clinical trials of treatments for coronavirus disease 2019 (Covid-19) have not
shown a significant benefit of postexposure prophylaxis. Methods We conducted a phase 2 …

[HTML][HTML] Co-infections among patients with COVID-19: The need for combination therapy with non-anti-SARS-CoV-2 agents?

CC Lai, CY Wang, PR Hsueh - Journal of Microbiology, Immunology and …, 2020 - Elsevier
Co-infection has been reported in patients with severe acute respiratory syndrome (SARS)
and Middle East respiratory syndrome, but there is limited knowledge on co-infection among …

Risk of gastrointestinal adverse events associated with glucagon-like peptide-1 receptor agonists for weight loss

M Sodhi, R Rezaeianzadeh, A Kezouh, M Etminan - Jama, 2023 - jamanetwork.com
Methods| We used a random sample of 16 million patients (2006-2020) from the PharMetrics
Plus for Academics database (IQVIA), a large health claims database that captures 93% of …

Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases …

JP Metlay, GW Waterer, AC Long… - American journal of …, 2019 - atsjournals.org
Background: This document provides evidence-based clinical practice guidelines on the
management of adult patients with community-acquired pneumonia. Methods: A …